As human cases of avian influenza slowly tick up amid the outbreak in U.S. dairy cattle, the Centers for Disease Control and ...

The phase 2 SHIMMER trial enrolled 130 patients with dementia with Lewy bodies who received either a 100-mg or a 300-mg dose ...

Flagship CEO-partner and Ring CEO Tuyen Ong, M.D., will also be shifting to an advisory role in the new year, according to ...

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a ...

SiteOne Therapeutics is powering up with $100 million to advance its early pipeline of non-opioid therapeutics that target ...

With Novo Nordisk’s name already synonymous with treatments for diabetes and obesity, the Danish drugmaker has been making a ...

Italian VC XGEN Venture has closed a 180 million euro ($190 million) fund for biotech and medtech companies. | Italian VC ...

Pruritus drug developer Cara Therapeutics kicked off the year halving its headcount, and the biotech has now found a new home ...

Alphabet spinoff SandboxAQ has raised more than $300 million to go toward developing AI applications across multiple areas ...

Freshly public BioAge Labs has secured a multi-year partnership with Novartis that focuses on age-related diseases and ...

The highest dose of Aurion Biotech’s cell therapy, the main component of which recently received approval in Japan, has ...

Roche has begun rolling out a new diagnostics system that aims to bring the gold-standard accuracy of mass spectrometry to ...